Tao Long, PhD is an intern of pharmacometrics at TRHC’s Precision Pharmacotherapy Research & Development Institute and a postdoctoral research associate at the University of Florida, College of Pharmacy’s Center for Pharmacometrics and Systems Pharmacology, working under the supervision by Dr. Stephan Schmidt. His current research project focuses on developing and verifying a physiologically-based pharmacokinetic (PBPK) model to evaluate the impact of drug-drug interactions (DDI) on the pharmacokinetics (PK) and pharmacodynamics (PD) of Tramadol when administered alone or in combination with enzyme perpetrator drugs.
Dr. Long earned his PhD in Pharmaceutical Sciences from School of Pharmacy at University of Pittsburgh. Dr. Long is the humble recipient of the Jonas Salk Fellowship, QIT Health Innovators Fellowship, Pitt-GPSG Leadership and Service Award and multiple research travel awards. Prior to joining TRHC and CPSP, Dr. Long worked as ORISE Fellow in Office of New Drug and Office of Clinical Pharmacology, US Food and Drug Administration.